-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
Congenital Anterior Urethrocutaneous Fistula: A Case Report
Changkai Deng, Qiang Peng, Xianliang Hu,Yang Lin, Fulin Li, Chao Ma, Feng Liu
Case Report: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Dual treatment approach may be the key to combating glioblastoma multiforme
News and Views: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation